Dr. Myra Ahmad, Founder & CEO of Mochi, joins Clint Betts for a conversation on obesity medicine, GLP-1 medications, telehealth, healthcare innovation, and the future of personalized metabolic care.Mochi is building a marketplace for evidence-based healthcare, helping patients connect with providers for customized treatment plans focused on obesity, metabolic health, menopause care, skincare, and more. In this episode, Dr. Ahmad explains why GLP-1 medications like Ozempic and Wegovy are fundamentally changing healthcare — and why obesity should be treated like any other chronic medical condition.The conversation also explores telemedicine, personalized medicine, healthcare costs, startup culture, compounding pharmacies, and the growing role of technology in healthcare delivery.00:00:00 - Introduction and Welcome00:00:13 - What is Mochi?00:00:31 - Revolution in Metabolic Health00:01:01 - Mochi's Unique Approach00:01:48 - Future of Healthcare00:02:11 - Dr. Ahmad's Background and Inspiration00:02:33 - The Obesity Epidemic00:03:37 - Factors Contributing to Obesity00:04:12 - Socioeconomic Factors in Obesity00:05:02 - Government and Food Industry's Role00:05:24 - Decline in Obesity Rates00:05:55 - Anti-GLP-1 Sentiment00:06:19 - Medication Management and Supervision00:07:29 - Personalized Medication and Compounding00:08:28 - Understanding Compounded GLP-1s00:09:47 - Future of Personalized Medication00:10:17 - Why Drugs are Expensive00:11:27 - A Day in the Life of a CEO00:12:05 - Funding and Profitability00:12:24 - Competitive Landscape00:13:18 - Building the Team and Culture00:13:37 - Advantages of Starting in San Francisco00:14:03 - Startup Culture in San Francisco00:14:55 - Reading Recommendations for CEOs00:15:29 - Regulatory Hurdles in Health Tech00:16:40 - Transition from Medicine to Startup00:17:42 - Impact of Being an MD00:18:29 - Macroeconomic Environment00:19:45 - Political Impact on Healthcare00:20:49 - Final Question: Who Gave You a Chance?00:21:21 - Closing Remarks and Future PlansIf you’re interested in healthcare, startups, telemedicine, GLP-1s, entrepreneurship, or the future of metabolic medicine, this conversation is packed with insights on where healthcare is heading next.Subscribe for more conversations with founders, CEOs, and leaders shaping the future of business and technology.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related